![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Niloy R. Datta, Susanne Rogers, Silvia Gómez Ordóñez, Emsad Puric & Stephan Bodis. (2016) Hyperthermia and radiotherapy in the management of head and neck cancers: A systematic review and meta-analysis. International Journal of Hyperthermia 32:1, pages 31-40.
Read now
Read now
Articles from other publishers (20)
Shunya Egawa, Yuki Maruyama, Sawa Arai, Tatsuya Kitajima, Hideyuki Awakura, Yukiomi Kushihashi, Kenichiro Ikeda, Hitome Kobayashi & Toshikazu Shimane. (2019) A Comparison between Radiography with Cisplatin and Cetuximab for Locally Advanced Head and Neck Cancer局所進行頭頸部癌に対するCisplatin併用放射線療法とCetuximab併用放射線療法の比較検討. Nihon Kikan Shokudoka Gakkai Kaiho 70:1, pages 17-24.
Crossref
Crossref
Pierluigi Bonomo, Mauro Loi, Isacco Desideri, Emanuela Olmetto, Camilla Delli Paoli, Francesca Terziani, Daniela Greto, Monica Mangoni, Silvia Scoccianti, Gabriele Simontacchi, Giulio Francolini, Icro Meattini, Saverio Caini & Lorenzo Livi. (2017) Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review. Critical Reviews in Oncology/Hematology 120, pages 98-110.
Crossref
Crossref
Jurga Remeikienė, Aista Plieskienė, Alvydas Česas & Jūratė Kasnauskienė. (2016) Safety And Toxicity Combining Radiation Therapy With A Biologic Therapy In Locally Advanced Head And Neck Squamous Cell Cancer At The Klaipeda University Hospital Clinical Practice. Sveikatos mokslai 26:5, pages 93-96.
Crossref
Crossref
Alberto Bonetta, Laura Bandera, Giandomenico Roviello, Ines Cafaro, Alberto Bottini & Daniele Generali. (2016) Neoadjuvant chemotherapy and radical radiotherapy associated with cetuximab for laryngeal cancer in a pancreas and renal recipient. Anti-Cancer Drugs 27:5, pages 470-473.
Crossref
Crossref
Nadeem Riaz, Eric Sherman, Lawrence Koutcher, Lauren Shapiro, Nora Katabi, Zhigang Zhang, Weiji Shi, Mathew Fury, Richard Wong, Suzanne Wolden, Shyam Rao & Nancy Lee. (2016) Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck. American Journal of Clinical Oncology 39:1, pages 27-31.
Crossref
Crossref
Gaku Takano, Daisuke Kawakita, Kei Ijichi, Shintaro Beppu & Shingo Murakami. (2016) The efficacy and safety of intensity modulated radiation therapy (IMRT) in combination with cetuximab for elderly patients with squamous cell carcinoma of the head and neck (SCCHN). JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY 25:3, pages 395-401.
Crossref
Crossref
Jacopo Giuliani & Andrea Bonetti. (2015) Cisplatin versus cetuximab given concomitantly with radiotherapy in non-resectable head and neck squamous cell carcinoma:an open question. European Archives of Oto-Rhino-Laryngology 273:1, pages 263-265.
Crossref
Crossref
T. Xu, Y. Liu, S. Dou, F. Li, X. Guan & G. Zhu. (2015) Weekly cetuximab concurrent with IMRT aggravated radiation-induced oral mucositis in locally advanced nasopharyngeal carcinoma: Results of a randomized phase II study. Oral Oncology 51:9, pages 875-879.
Crossref
Crossref
Nicolas Dornoff, Christian Weiß, Franz Rödel, Jens Wagenblast, Shahram Ghanaati, Nateghian Atefeh, Claus Rödel & Panagiotis Balermpas. (2015) Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neckRebestrahlung mit Cetuximab oder cisplatinbasierter Chemotherapie bei rezidivierten Plattenepithelkarzinomen der Kopf-Hals-Region. Strahlentherapie und Onkologie 191:8, pages 656-664.
Crossref
Crossref
Tejpal Gupta, Sadhana Kannan, Sarbani Ghosh-Laskar & Jai Prakash Agarwal. (2015) Concomitant chemoradiotherapy versus altered fractionation radiotherapy in the radiotherapeutic management of locoregionally advanced head and neck squamous cell carcinoma: An adjusted indirect comparison meta-analysis. Head & Neck 37:5, pages 670-676.
Crossref
Crossref
Primož Strojan, Cvetka Grašič Kuhar, Barbara Žumer, Maksimilijan Kadivec, Katarina Karner, Igor Fajdiga, Boris Jančar, Nina Gale, Mario Poljak, Boštjan J Kocjan & Branko Zakotnik. (2014) TPF induction chemotherapy and concomitant irradiation with cisplatin and cetuximab in unresectable squamous cell carcinoma of the head and neck. Head & Neck 36:11, pages 1555-1561.
Crossref
Crossref
S Skvortsov, J Dudás, P Eichberger, M Witsch-Baumgartner, J Loeffler-Ragg, C Pritz, V H Schartinger, H Maier, J Hall, P Debbage, H Riechelmann, P Lukas & I Skvortsova. (2014) Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC). British Journal of Cancer 110:11, pages 2677-2687.
Crossref
Crossref
Jacopo Giuliani & Marina Marzola. (2014) Cetuximab/cisplatin and radiotherapy in HNSCC: is there a favorite choice?. Open Medicine 9:2, pages 279-284.
Crossref
Crossref
S Aval, L Pabla & L M Flood. (2013) The National Institute for Health and Clinical Excellence, and otolaryngology: review of the evidence. The Journal of Laryngology & Otology 128:1, pages 2-12.
Crossref
Crossref
Neil Gildener-Leapman, Robert L. Ferris & Julie E. Bauman. (2013) Promising systemic immunotherapies in head and neck squamous cell carcinoma. Oral Oncology 49:12, pages 1089-1096.
Crossref
Crossref
Alvydas Česas, Aista Plieskienė, Jolanta Česienė & Jurga Kanišauskaitė. (2013) Sutaptinis vietiškai išplitusių galvos-kaklo piktybinių navikų gydymas biologine ir spinduline terapijaConcomitant Bioradiotherapy of Locally Advanced Head and Neck Cancer at the Klaipeda University Hospital. Sveikatos mokslai 23:3, pages 24-26.
Crossref
Crossref
Md. Abdul Hye Khan, Jing Liu, Ganesh Kumar, Stephen X. Skapek, John R. Falck & John D. Imig. (2013) Novel orally active epoxyeicosatrienoic acid (EET) analogs attenuate cisplatin nephrotoxicity. The FASEB Journal 27:8, pages 2946-2956.
Crossref
Crossref
S. Okano, T. Yoshino, M. Fujii, Y. Onozawa, T. Kodaira, H. Fujii, T. Akimoto, S. Ishikura, M. Oguchi, S. Zenda, B. de Blas & M. Tahara. (2013) Phase II Study of Cetuximab Plus Concomitant Boost Radiotherapy in Japanese Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Japanese Journal of Clinical Oncology 43:5, pages 476-482.
Crossref
Crossref
Nadeem Riaz, Eric J. Sherman, Matthew Fury & Nancy Lee. (2013) Should Cetuximab Replace Cisplatin for Definitive Chemoradiotherapy in Locally Advanced Head and Neck Cancer?. Journal of Clinical Oncology 31:2, pages 287-288.
Crossref
Crossref
S. K. Kundu & M. Nestor. (2012) Targeted therapy in head and neck cancer. Tumor Biology 33:3, pages 707-721.
Crossref
Crossref